Trisindoline synthesis and anticancer activity

Miyoun Yoo, Sang Un Choi, Ki Young Choi, Gyu Hwan Yon, Jong Chan Chae, Dockyu Kim, Gerben J. Zylstra, Eungbin Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Expression of a Rhodococcus-derived oxygenase gene in Escherichia coli yielded indigo metabolites with cytotoxic activity against cancer cells. Bioactivity-guided fractionation of these indigo metabolites led to the isolation of trisindoline as the agent responsible for the observed in vitro cytotoxic activity against cancer cells. While the cytotoxicity of etoposide, a common anticancer drug, was dramatically decreased in multidrug-resistant (MDR) cancer cells compared with treatment of parental cells, trisindoline was found to have similar cytotoxicity effects on both parental and MDR cell lines. In addition, the cytotoxic effects of trisindoline were resistant to P-glycoprotein overexpression, one of the most common mechanisms of drug resistance in cancer cells, supporting its use to kill MDR cancer cells.

Original languageEnglish
Pages (from-to)96-99
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume376
Issue number1
DOIs
Publication statusPublished - 2008 Nov 7

Fingerprint

Cells
Indigo Carmine
Neoplasms
Cytotoxicity
Metabolites
Rhodococcus
Oxygenases
P-Glycoprotein
Etoposide
Drug Resistance
Fractionation
Bioactivity
trisindoline
Pharmaceutical Preparations
Escherichia coli
Genes
Cell Line

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Yoo, Miyoun ; Choi, Sang Un ; Choi, Ki Young ; Yon, Gyu Hwan ; Chae, Jong Chan ; Kim, Dockyu ; Zylstra, Gerben J. ; Kim, Eungbin. / Trisindoline synthesis and anticancer activity. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 376, No. 1. pp. 96-99.
@article{a87a8fcb7ee141479ea280d36cefe406,
title = "Trisindoline synthesis and anticancer activity",
abstract = "Expression of a Rhodococcus-derived oxygenase gene in Escherichia coli yielded indigo metabolites with cytotoxic activity against cancer cells. Bioactivity-guided fractionation of these indigo metabolites led to the isolation of trisindoline as the agent responsible for the observed in vitro cytotoxic activity against cancer cells. While the cytotoxicity of etoposide, a common anticancer drug, was dramatically decreased in multidrug-resistant (MDR) cancer cells compared with treatment of parental cells, trisindoline was found to have similar cytotoxicity effects on both parental and MDR cell lines. In addition, the cytotoxic effects of trisindoline were resistant to P-glycoprotein overexpression, one of the most common mechanisms of drug resistance in cancer cells, supporting its use to kill MDR cancer cells.",
author = "Miyoun Yoo and Choi, {Sang Un} and Choi, {Ki Young} and Yon, {Gyu Hwan} and Chae, {Jong Chan} and Dockyu Kim and Zylstra, {Gerben J.} and Eungbin Kim",
year = "2008",
month = "11",
day = "7",
doi = "10.1016/j.bbrc.2008.08.092",
language = "English",
volume = "376",
pages = "96--99",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Yoo, M, Choi, SU, Choi, KY, Yon, GH, Chae, JC, Kim, D, Zylstra, GJ & Kim, E 2008, 'Trisindoline synthesis and anticancer activity', Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 96-99. https://doi.org/10.1016/j.bbrc.2008.08.092

Trisindoline synthesis and anticancer activity. / Yoo, Miyoun; Choi, Sang Un; Choi, Ki Young; Yon, Gyu Hwan; Chae, Jong Chan; Kim, Dockyu; Zylstra, Gerben J.; Kim, Eungbin.

In: Biochemical and Biophysical Research Communications, Vol. 376, No. 1, 07.11.2008, p. 96-99.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trisindoline synthesis and anticancer activity

AU - Yoo, Miyoun

AU - Choi, Sang Un

AU - Choi, Ki Young

AU - Yon, Gyu Hwan

AU - Chae, Jong Chan

AU - Kim, Dockyu

AU - Zylstra, Gerben J.

AU - Kim, Eungbin

PY - 2008/11/7

Y1 - 2008/11/7

N2 - Expression of a Rhodococcus-derived oxygenase gene in Escherichia coli yielded indigo metabolites with cytotoxic activity against cancer cells. Bioactivity-guided fractionation of these indigo metabolites led to the isolation of trisindoline as the agent responsible for the observed in vitro cytotoxic activity against cancer cells. While the cytotoxicity of etoposide, a common anticancer drug, was dramatically decreased in multidrug-resistant (MDR) cancer cells compared with treatment of parental cells, trisindoline was found to have similar cytotoxicity effects on both parental and MDR cell lines. In addition, the cytotoxic effects of trisindoline were resistant to P-glycoprotein overexpression, one of the most common mechanisms of drug resistance in cancer cells, supporting its use to kill MDR cancer cells.

AB - Expression of a Rhodococcus-derived oxygenase gene in Escherichia coli yielded indigo metabolites with cytotoxic activity against cancer cells. Bioactivity-guided fractionation of these indigo metabolites led to the isolation of trisindoline as the agent responsible for the observed in vitro cytotoxic activity against cancer cells. While the cytotoxicity of etoposide, a common anticancer drug, was dramatically decreased in multidrug-resistant (MDR) cancer cells compared with treatment of parental cells, trisindoline was found to have similar cytotoxicity effects on both parental and MDR cell lines. In addition, the cytotoxic effects of trisindoline were resistant to P-glycoprotein overexpression, one of the most common mechanisms of drug resistance in cancer cells, supporting its use to kill MDR cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=52049112527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049112527&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.08.092

DO - 10.1016/j.bbrc.2008.08.092

M3 - Article

C2 - 18760995

AN - SCOPUS:52049112527

VL - 376

SP - 96

EP - 99

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -